The relationship between quality of life and the severity of psoriasis in Turkey
- PMID: 25655046
- DOI: 10.1684/ejd.2014.2511
The relationship between quality of life and the severity of psoriasis in Turkey
Abstract
Background: Patients with psoriasis experience a low quality of life and high treatment burden:
Objectives: To assess psoriatic patient quality of life using the Dermatology Life Quality Index (DLQI) in the Northeastern Anatolia region of Turkey. Additionally, we evaluated the correlation between the DLQI and the clinical severity of psoriasis and examined demographic data and their relationship with the DLQI and psoriasis severity:
Materials and methods: This study was a single-center, prospective, cross-sectional study at the University of Kafkas, Kars, Turkey. 127 adult patients were included in the study. The Turkish version of the DLQI was used. To measure psoriasis severity, the Psoriasis Area Severity Index (PASI) and Body Surface Area (BSA) were simultaneously evaluated. The patient demographics were compared with quality of life and the severity of psoriasis:
Results: DLQI scores ranged from "very large" to "extremely large" in 61% of the patients. The psoriasis severity (BSA and PASI) was "mild" in 63% of patients. The quality of life was significantly affected in cigarette smokers and in patients whose disease included nail involvement. The PASI and BSA scores of patients with scalp and nail involvement were significantly higher. A significant, positive correlation was found between disease duration and the severity of psoriasis. BSA correlated with PASI:
Conclusion: The quality of life of psoriasis patients is strongly reduced. A significant relationship was found for DLQI with nail psoriasis and smoking. A linear, positive correlation was detected between the DLQI and BSA but not between the DLQI and PASI.
Keywords: Demographic analysis; Psoriasis; Quality of Life.
Similar articles
-
Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).J Eur Acad Dermatol Venereol. 2015 Mar;29(3):452-6. doi: 10.1111/jdv.12576. Epub 2014 Jun 9. J Eur Acad Dermatol Venereol. 2015. PMID: 24911993
-
Impact of functional pruritus compared with mild psoriasis on quality of life: a cross-sectional questionnaire study in Turkey.Am J Clin Dermatol. 2014 Aug;15(4):365-70. doi: 10.1007/s40257-014-0075-7. Am J Clin Dermatol. 2014. PMID: 24756248
-
Psoriasis affects patient's quality of life more seriously in female than in male in Japan.Tokai J Exp Clin Med. 2012 Sep 20;37(3):84-8. Tokai J Exp Clin Med. 2012. PMID: 23032250
-
Moderate Psoriasis: A Proposed Definition.Actas Dermosifiliogr. 2017 Dec;108(10):911-917. doi: 10.1016/j.ad.2017.07.002. Epub 2017 Aug 17. Actas Dermosifiliogr. 2017. PMID: 28823420 Review. English, Spanish.
-
Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact.J Eur Acad Dermatol Venereol. 2021 Feb;35(2):417-421. doi: 10.1111/jdv.16966. Epub 2020 Dec 9. J Eur Acad Dermatol Venereol. 2021. PMID: 32978847
Cited by
-
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.J Clin Med. 2023 Dec 24;13(1):101. doi: 10.3390/jcm13010101. J Clin Med. 2023. PMID: 38202108 Free PMC article.
-
Acceptance of Illness, Satisfaction with Life, Sense of Stigmatization, and Quality of Life among People with Psoriasis: A Cross-Sectional Study.Dermatol Ther (Heidelb). 2020 Jun;10(3):413-430. doi: 10.1007/s13555-020-00368-w. Epub 2020 Mar 19. Dermatol Ther (Heidelb). 2020. PMID: 32193842 Free PMC article.
-
Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real-world evidence in Japan.J Dermatol. 2021 Feb;48(2):175-183. doi: 10.1111/1346-8138.15655. Epub 2020 Oct 25. J Dermatol. 2021. PMID: 33099791 Free PMC article.
-
Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society.Dermatol Ther (Heidelb). 2019 Dec;9(4):725-734. doi: 10.1007/s13555-019-00322-5. Epub 2019 Sep 11. Dermatol Ther (Heidelb). 2019. PMID: 31512178 Free PMC article.
-
Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?Life (Basel). 2021 Oct 28;11(11):1151. doi: 10.3390/life11111151. Life (Basel). 2021. PMID: 34833027 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous